Home » Topics » Briefs » Other news to note

Other news to note
RSS

Victoria Enterprises-BioQuest merger

Oct. 11, 1996

Cambridge Biotech set to implement reorganization plan

Oct. 11, 1996

ICN expands its presence in Russia

Oct. 11, 1996

Hypnotic agent in the Fujisawa pipeline

Oct. 11, 1996

Future metabolic agents in the Yamanouchi pipeline

Oct. 11, 1996

Antineoplastic aromatase inhibitor from Yamanouchi shows potential for hormone-related illnesses

Oct. 11, 1996

Fujisawa pursues new indications for tacrolimus

Oct. 11, 1996

Celecoxib development status in Japan

Oct. 11, 1996

Yamanouchi awaits marketing approval for Farom

Oct. 11, 1996

Fujisawa antibiotic awaiting MHW approval

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.